Fosheim G E, Carey R B, Limbago B M
Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, MS C16, 1600 Clifton Rd., Atlanta, GA 30333, USA.
J Clin Microbiol. 2007 May;45(5):1611-3. doi: 10.1128/JCM.02556-06. Epub 2007 Mar 7.
AdvanDx VRE EVIGENE, a commercial vanA/vanB DNA hybridization assay to identify vancomycin-resistant enterococci (VRE), was evaluated for the detection of vanA in Staphylococcus aureus. Performance was assessed using S. aureus, VRE, and vancomycin-intermediate and -susceptible isolates. The assay demonstrated 100% sensitivity and specificity when analyzed visually and by optical density.
AdvanDx公司的VRE EVIGENE是一种用于鉴定耐万古霉素肠球菌(VRE)的商业化vanA/vanB DNA杂交检测法,该检测法针对金黄色葡萄球菌中vanA的检测进行了评估。使用金黄色葡萄球菌、VRE以及万古霉素中介和敏感菌株评估了其性能。该检测法在目视分析和光密度分析时均显示出100%的灵敏度和特异性。